Do drug and opioid use vary by spousal sexual orientation and military status

Abstract: The purpose of the present study was to explore the differences in illicit drug use and opioid misuse according to the sexual orientation of spouses in the military and spouses not in the military. Data were retrieved from the 2015-2019 waves of the National Survey of Drug Use and Health (military n = 905; civilian n = 1,865). Differences in drug use and opioid misuse by sexual orientation and military status were tested in stratified Poisson regression models, adjusting for sociodemographic variables, psychological distress, and health conditions. Any drug use in the past year was higher among spouses of active-duty service members (4.42%) than among spouses of civilians (1.55%, chi(2) = 20.59, p < .001). Any opioid misuse was higher among spouses of active-duty service members (7.29%) than among spouses of civilians (4.29%, chi(2) = 11.01, p = .001). In adjusted models, sexual minority status was a risk factor for drug use, but not opioid misuse, among military spouses; however, sexual minority status was a risk factor for both drug use and opioid misuse among civilian spouses. We showed that illicit drug use among spouses of active-duty service members may be higher than spouses of civilians, especially for sexual minorities; however, sexual minority status may only be a risk factor for civilian couples.

Read the full article
Report a problem with this article

Related articles

  • More for Researchers

    Identifying opioid relapse during COVID-19 using natural language processing of nationwide Veterans Health Administration electronic medical record data

    Abstract: Novel and automated means of opioid use and relapse risk detection are needed. Unstructured electronic medical record data, including written progress notes, can be mined for clinically relevant information, including the presence of substance use and relapse-critical markers of risk and recovery from opioid use disorder (OUD). In this study, we used natural language processing (NLP) to automate the extraction of opioid relapses, and the timing of these occurrences, from veteran patients' electronic medical record. We then demonstrated the utility of our NLP tool via analysis of pre-/post-COVID-19 opioid relapse trends among veterans with OUD. For this demonstration, we analyzed data from 107,606 veterans OUD enrolled in Veterans Health Administration, comparing a pandemic-exposed cohort (n = 53,803; January 2019-March 2021) to a matched prepandemic cohort (n = 53,803; October 2017-December 2019). The recall of our NLP tool was 75% and our precision was 94%, demonstrating moderate sensitivity and excellent specificity. Using the NLP tool, we found that the odds of opioid relapse postpandemic onset were proportionally higher compared to prepandemic trends, despite patients having fewer mental health encounters from which to derive instances of relapse postpandemic onset. In this research application of the tool, and as hypothesized, we found that opioid relapse risk was elevated postpandemic. The application of NLP Methods: to identify and monitor relapse risk holds promise for future surveillance, risk prevention, and clinical outcome research.